Endometrial cancer

EJ Crosbie, SJ Kitson, JN McAlpine, A Mukhopadhyay… - The Lancet, 2022 - thelancet.com
Endometrial cancer is the most common gynaecological cancer in high income countries
and its incidence is rising globally. Although an ageing population and fewer benign …

Current and emerging prognostic biomarkers in endometrial cancer

K Njoku, CE Barr, EJ Crosbie - Frontiers in Oncology, 2022 - frontiersin.org
Endometrial cancer is the most common gynaecological malignancy in high income
countries and its incidence is rising. Whilst most women with endometrial cancer are …

Menopause, wellbeing and health: A care pathway from the European Menopause and Andropause Society

I Lambrinoudaki, E Armeni, D Goulis, S Bretz, I Ceausu… - Maturitas, 2022 - Elsevier
This care pathway from the European Menopause and Andropause Society (EMAS)
provides an updated pathway for monitoring and guidance of women at midlife, focusing on …

Current approaches to the management of patients with endometrial cancer

E Kalampokas, G Giannis, T Kalampokas… - Cancers, 2022 - mdpi.com
Simple Summary New data, the development of new methods of treatment and management
and the rising incidence of endometrial cancer require constant reviewing, in order to inform …

Efficacy and safety of PD-1/PD-L1 inhibitor as single-agent immunotherapy in endometrial cancer: a systematic review and meta-analysis

MN Mamat@ Yusof, KT Chew, AMHA Hafizz… - Cancers, 2023 - mdpi.com
Simple Summary The programmed cell death protein 1 (PD-1)/programmed cell death
ligand 1 (PD-L1) pathway controls the induction and maintenance of immune tolerance …

Impact of pre-treatment prognostic nutritional index and the haemoglobin, albumin, lymphocyte and platelet (HALP) score on endometrial cancer survival: A …

K Njoku, CE Barr, NC Ramchander, EJ Crosbie - PloS one, 2022 - journals.plos.org
Purpose The Onodera's prognostic nutritional index (PNI) and the haemoglobin, albumin,
lymphocyte and platelet (HALP) score are immune-nutritional indices that correlate with …

Expression of PD-1 and PD-L1 in endometrial cancer: molecular and clinical significance

MN Mamat@ Yusof, KT Chew, NC Kampan… - International Journal of …, 2023 - mdpi.com
The landscape of diagnosing and treating endometrial cancer is undergoing a profound
transformation due to the integration of molecular analysis and innovative therapeutic …

[HTML][HTML] Gynecological malignancies and obesity

HJ Agnew, SJ Kitson, EJ Crosbie - Best Practice & Research Clinical …, 2023 - Elsevier
The global pandemic of obesity has had a significant impact on gynecological malignancies,
most notably endometrial cancer. It has resulted in worldwide increases in the incidence of …

Quantitative SWATH-based proteomic profiling of urine for the identification of endometrial cancer biomarkers in symptomatic women

K Njoku, A Pierce, B Geary, AE Campbell… - British journal of …, 2023 - nature.com
Background A non-invasive endometrial cancer detection tool that can accurately triage
symptomatic women for definitive testing would improve patient care. Urine is an attractive …

Impact of type 2 diabetes mellitus on endometrial cancer survival: a prospective database analysis

K Njoku, HJ Agnew, EJ Crosbie - Frontiers in Oncology, 2022 - frontiersin.org
Purpose Type 2 diabetes mellitus (T2DM) is an established risk factor for endometrial cancer
but its impact on endometrial cancer survival outcomes is unclear. The aim of this study was …